TherapeuticsMD Stock Price

0.02 (0.2%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 611,567
Bid Price 9.92
Ask Price 9.98
News -
Day High 9.97


52 Week Range


Day Low 9.91
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
TherapeuticsMD Inc TXMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.02 0.2% 9.92 20:00:00
Open Price Low Price High Price Close Price Prev Close
9.94 9.91 9.97 9.92 9.90
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,380 611,567 $ 9.93 $ 6,073,491 - 0.1503 - 10.17
Last Trade Time Type Quantity Stock Price Currency
19:48:09 1 $ 9.95 USD


Draw Mode:

TherapeuticsMD Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 87.40M 8.81M 8.73M $ 86.95M $ - -21.67 -0.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 5.79M 6.50%

more financials information »

TherapeuticsMD News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TXMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week9.9410.059.8759.911,293,205-0.02-0.2%
1 Month9.5410.179.129.931,655,5620.383.98%
3 Months0.379510.170.15031.834,338,2299.542,513.97%
6 Months0.405510.170.15030.81977766,063,1079.512,346.36%
1 Year1.2210.170.15030.79032075,653,0038.70713.11%
3 Years2.4910.170.15031.425,672,3147.43298.39%
5 Years5.2510.170.15032.274,679,3284.6788.95%

TherapeuticsMD Description

TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220628 07:00:21